The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 1, 2002, Pages 17-23

  Schellenberg, David ^a   Kahigwa, Elizeus ^a   Drakeley, Chris ^a   Malende, Athumani ^a   Wigayi, John ^a   Msokame, Chris ^a   Aponte, John J ^a   Tanner, Marcel ^a   Mshinda, Hassan ^a   Menendez, Clara ^a   Alonso, Pedro L ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; FANSIDAR;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; GAMETOCYTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TANZANIA; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING; WORLD HEALTH ORGANIZATION;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036655646     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.17     Document Type: Article

References (28)

1. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population
2. Impact of chloroquine resistance on malaria mortality
3. Averting a malaria disaster
4. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double-blind, randomised, controlled trial
5. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: Selective pressure for resistance is a function of long elimination half-life
6. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
7. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimthamine in children in Tanzania
8. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya
9. Antimalarial drug resistance: The pace quickens
10. Systematic review of amodiaquine treatment in uncomplicated malaria
11. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine
12. Management of severe malarial anaemia in Gambian children
13. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria - A systematic review
14. Adverse reactions to sulpha drugs: Implications for malaria chemotherapy
15. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants
16. Efficacy and safety of CGP56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years
17. Monitoring the response of malaria infections to treatment
18. A community perspective on the efficacy off malaria treatment options for children in Lundazi District, Zambia
19. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: A randomised, placebo-controlled trial
20. Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae S.S. mosquitoes
21. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine